• PEG 400 Enhances Quercetin Exposure and Anti-Inflammation

  2026-09-28

  The reference study shows that polyethylene glycol 400 substantially increases quercetin and quercetin-3-O-glucuronide exposure while improving anti-inflammatory activity in rats. By combining pharmacokinetics, spatial mass spectrometry imaging, enzyme and transporter assays, and an edema model, it connects formulation excipient effects with metabolic and efflux processes.

• Dicloxacillin Activity Against Intracellular S. aureus

  2026-09-28

  Sandberg and colleagues combined THP-1 cell experiments with a mouse peritonitis model to examine dicloxacillin activity against intracellular and extracellular Staphylococcus aureus. Their results show why compartment-specific measurements and pharmacokinetic/pharmacodynamic analysis matter: free-drug time above MIC best predicted efficacy in both compartments, while outcomes differed across models and sampling times.

• LY2886721: Practical BACE1 Inhibition Workflows

  2026-09-27

  Use LY2886721 to connect BACE1 target engagement with amyloid-beta measurements and neuronal function—not just a single endpoint. This guide translates evidence for moderate Aβ reduction into a dose-ranging workflow, with practical controls and troubleshooting for cell-based studies.

• 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) Assays

  2026-09-26

  A practical guide to using N2703 as an investigational small-molecule input in cell viability, proliferation, and cytotoxicity workflows. It covers solubility, handling, controls, interpretation limits, and how to assess product documentation without mistaking chemical characterization for assay validation.

• Engineered Klotho mRNA Reverses iMSC Senescence

  2026-09-25

  The study used hyperbranched poly(β-amino ester)s to deliver engineered Klotho mRNA to aged and Klotho-deficient induced mesenchymal stem cells (iMSCs). Klotho expression was restored alongside improvements in senescence-associated and mitochondrial readouts, supporting further investigation of transient mRNA delivery as a strategy for cellular rejuvenation.

• SIM@ZIF-8 Hydrogel for Osteoporotic Bone Repair

  2026-09-25

  This study presents a photo-crosslinked chitosan–gelatin hydrogel that combines simvastatin-loaded ZIF-8 nanoparticles with sustained zinc-ion release. In in vitro and in vivo experiments, the system was reported to support cell recruitment, osteogenesis, and angiogenesis, offering a coordinated biomaterial strategy for bone repair in an osteoporotic environment.

• Partial BACE Inhibition and Synaptic Transmission

  2026-09-24

  Satir and colleagues tested whether partial BACE inhibition can lower amyloid-β secretion without disrupting synaptic transmission in cultured rat cortical neurons. Their results identify a potentially useful experimental range—amyloid-β reduction of up to about 50%—while showing that stronger inhibition can coincide with reduced transmission, a distinction relevant to Alzheimer’s disease treatment research.

• Esculetin Limits CKLF1-Driven Inflammation After Stroke

  2026-09-24

  In a mouse photothrombotic stroke model, esculetin was associated with smaller infarcts, improved behavioral outcomes and changes in motor-network functional MRI measures. The study links these effects to reduced CKLF1–CCR5 signaling and neutrophil recruitment, while its knockout results support CKLF1 dependence without establishing that esculetin directly binds CKLF1 or CCR5.

• LY2886721: BACE Inhibitor Evidence and Research Use

  2026-09-23

  LY2886721 is an oral BACE inhibitor used to investigate amyloid precursor protein processing and amyloid beta reduction. Product-reported potency and mouse data support its use as a research tool, while neuronal-culture findings show that synaptic effects depend on the degree of BACE inhibition.

• AMG 487 CXCR3 Antagonist Workflow

  2026-09-23

  AMG 487 provides a practical way to separate CXCR3-dependent calcium signaling, chemotaxis, and macrophage-state effects. This workflow translates potency data and the LAMP1–CXCL10–CXCR3 findings into assay-ready dosing, controls, and troubleshooting decisions.

• Prestained Protein Marker for LARP1 Assays

  2026-09-22

  Build clearer LARP1–ribosome experiments with a Triple color protein ladder that tracks separation, transfer, and molecular size from 10 to 250 kDa. Its EDTA-free formulation is especially useful for Phosbind workflows and fluorescent membrane imaging.

• GelMA/QCS/Ca2+ Adhesive for Non-Compressible Hemorrhage

  2026-09-22

  This study reports an injectable GelMA/QCS/Ca2+ double-network adhesive that combines blue-light-triggered gelation with QCS-associated antibacterial activity for non-compressible bleeding and infected wounds. Across mouse hemostasis and antibacterial models, the formulation outperformed fibrin glue and single-function hydrogels, although translation beyond acute animal models remains to be established.

• AMG 487: CXCR3 Antagonist Workflow Guide

  2026-09-21

  AMG 487 enables controlled interrogation of CXCR3-dependent chemotaxis, calcium signaling, and macrophage-state transitions. Its strongest use-case is a matched workflow that connects quantitative receptor pharmacology with state-dependent inflammatory biology while controlling formulation and metabolism.

• Safe DNA Gel Stain for Reliable Gel QC

  2026-09-21

  Learn how Safe DNA Gel Stain (SKU A8743) supports safer DNA and RNA gel visualization, nucleic acid quality control, and reproducible molecular workflows connected to cell viability and cytotoxicity studies. The article provides scenario-based guidance on dilution, excitation, storage, interpretation, and vendor selection.

• AMG 487 Workflow for CXCR3 Signaling

  2026-09-20

  AMG 487 provides a nanomolar pharmacological handle for separating CXCR3-dependent migration, calcium signaling, and macrophage-state effects. This workflow translates the CXCL10–CXCR3–LAMP1 findings into practical assay design, dosing, controls, and troubleshooting decisions.

554 records 3/37 page Previous Next 12345 下5页 Last page